| 000 | 01692 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513031150.0 | ||
| 264 | 0 | _c19941121 | |
| 008 | 199411s 0 0 eng d | ||
| 022 | _a0393-6155 | ||
| 024 | 7 |
_a10.1177/172460089400900204 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStieber, P | |
| 245 | 0 | 0 |
_aComparison of CYFRA 21-1, TPA and TPS in lung cancer, urinary bladder cancer and benign diseases. _h[electronic resource] |
| 260 |
_bThe International journal of biological markers _c |
||
| 300 |
_a82-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAutomation |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xblood |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xblood |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 | _aDisease |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKeratins _xblood |
| 650 | 0 | 4 |
_aLung Neoplasms _xblood |
| 650 | 0 | 4 |
_aPeptide Fragments _xblood |
| 650 | 0 | 4 |
_aPeptides _xblood |
| 650 | 0 | 4 | _aReagent Kits, Diagnostic |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aTissue Polypeptide Antigen |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xblood |
| 700 | 1 | _aDienemann, H | |
| 700 | 1 | _aHasholzner, U | |
| 700 | 1 | _aFabricius, P G | |
| 700 | 1 | _aSchambeck, C | |
| 700 | 1 | _aWeinzierl, M | |
| 700 | 1 | _aPoley, S | |
| 700 | 1 | _aSamtleben, W | |
| 700 | 1 | _aHofmann, K | |
| 700 | 1 | _aMeier, W | |
| 773 | 0 |
_tThe International journal of biological markers _gvol. 9 _gno. 2 _gp. 82-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/172460089400900204 _zAvailable from publisher's website |
| 999 |
_c7523017 _d7523017 |
||